Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001104659-19-076222

Director acquired 3,940,887 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SPRINGER TIMOTHY A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-23 Grant or award : show line 1 in the form +3,940,887 $1.46 $5,753,695 5,486,463 I

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2019-12-23 Grant or award : show line 2 in the form Warrants +1,970,443 $0.13 $246,305 $1.46 2024-12-23 1,970,443 1,970,443 I
Loading xslF345X03/a4.xml…